David Rescott Analyst PerformanceSenior Research Analyst - Medical Technology at Robert W. BairdDavid Rescott is a stock analyst at Robert W. Baird in the healthcare sector, covering 12 publicly traded companies. Over the past year, David Rescott has issued 41 stock ratings, including strong buy, buy, and hold recommendations. While full access to David Rescott's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Rescott's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings62 Last 4 YearsBuy Recommendations68.75% 33 Buy RatingsCompanies Covered12 Unique Companies Ratings Distribution48RatingsDistribution of strong buy, buy, hold, and sell ratings by David Rescott.RatingPercentageCount Strong Buy2.1%1 ratings Buy66.7%32 ratings Hold31.3%15 ratings Sell0.0%0 ratingsOut of 48 total stock ratings issued by David Rescott at Robert W. Baird, the majority (66.7%) have been Buy recommendations, followed by 31.3% Hold and 2.1% Strong Buy.Best & Worst CallsBest Call000.0%LIVNMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BSXJul 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE50.0% of companies on NYSE6 companiesNASDAQ50.0% of companies on NASDAQ6 companiesDavid Rescott, an analyst at Robert W. Baird, currently covers 12 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageHealthcare12 companies100.0%David Rescott of Robert W. Baird specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageHEALTHCARE EQUIPMENT & SUPPLIES11 companies91.7%HEALTHCARE TECHNOLOGY1 company8.3% About David RescottDavid Rescott is Baird’s Senior Research Analyst covering Medical Technology. Prior to joining Baird in 2023, David served as an Equity Research Analyst covering U.S. Medical Supplies & Devices at Truist Securities and previously as an Associate. David also previously worked as an Associate covering Biomedical Devices and Services at Canaccord Genuity. David received a BS in Business Administration and French from State University of New York at Geneseo and a Master of Science in Finance from Vanderbilt University. David Rescott's Ratings History at Robert W. Baird Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsHAEHaemonetics8/7/2026Set Price Target$86.16$96.00$0.0000.00% ROIMMSIMerit Medical Systems7/31/2026Set Price Target$84.20$98.00$0.0000.00% ROIHTFLHeartflow7/31/2026Initiated Coverage$25.83$34.00Outperform$0.0000.00% ROIHTFLHeartflow7/31/2026Initiated Coverage$25.23$34.00Outperform$0.0000.00% ROIBSXBoston Scientific7/30/2026Set Price Target$46.07$56.00$0.0000.00% ROIISRGIntuitive Surgical7/17/2026Lower Price Target$402.33$500.00Outperform$0.0000.00% ROIABTAbbott Laboratories7/1/2026Initiated Coverage$90.68$121.00Outperform$0.0000.00% ROIABTAbbott Laboratories6/30/2026Upgrade$95.25Strong-Buy$0.0000.00% ROIMDTMedtronic6/4/2026Lower Price Target$78.09$85.00Neutral$0.0000.00% ROIBSXBoston Scientific5/28/2026Set Price Target$50.34$70.00$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. BSXBoston Scientific5/19/2026Lower Price Target$55.86$75.00Outperform$0.0000.00% ROIHAEHaemonetics5/8/2026Set Price Target$53.74$67.00$0.0000.00% ROILIVNLivaNova5/7/2026Lower Price Target$66.26$76.00Outperform$0.0000.00% ROIMMSIMerit Medical Systems5/1/2026Set Price Target$64.54$83.00$0.0000.00% ROIEWEdwards Lifesciences4/24/2026Boost Price Target$79.69$87.00Neutral$0.0000.00% ROIBSXBoston Scientific4/23/2026Lower Price Target$64.95$78.00Outperform$0.0000.00% ROIISRGIntuitive Surgical4/22/2026Boost Price Target$487.27$610.00Outperform$0.0000.00% ROIPRCTPROCEPT BioRobotics3/6/2026Initiated Coverage$25.35$30.00Neutral$0.0000.00% ROIPRCTPROCEPT BioRobotics3/5/2026Upgrade$25.26Hold$0.0000.00% ROISIBNSiBone2/24/2026Reiterated Rating$15.62$24.00Buy$0.0000.00% ROIMDTMedtronic2/18/2026Lower Price Target$96.33$100.00Neutral$0.0000.00% ROIHAEHaemonetics2/6/2026Set Price Target$61.31$81.00$0.0000.00% ROIBSXBoston Scientific2/5/2026Lower Price Target$75.50$101.00Outperform$0.0000.00% ROIPENPenumbra1/16/2026Reiterated Rating$350.53$374.00Neutral$0.0000.00% ROIPENPenumbra1/16/2026Downgrade$350.93$374.00Hold$0.0000.00% ROIEWEdwards Lifesciences1/12/2026Set Price Target$83.66$90.00$0.0000.00% ROISIBNSiBone12/18/2025Boost Price Target$19.63$23.00Buy$0.0000.00% ROIPENPenumbra12/16/2025Set Price Target$308.72$345.00$0.0000.00% ROIMMSIMerit Medical Systems12/16/2025Set Price Target$86.41$108.00$0.0000.00% ROIMDTMedtronic12/16/2025Set Price Target$98.68$103.00$0.0000.00% ROILIVNLivaNova12/16/2025Set Price Target$63.06$75.00$0.0000.00% ROIEWEdwards Lifesciences12/16/2025Set Price Target$83.41$87.00Neutral$0.0000.00% ROIHAEHaemonetics12/15/2025Boost Price Target$80.27$99.00Outperform$0.0000.00% ROIEWEdwards Lifesciences12/5/2025Boost Price Target$85.72$88.00Neutral$0.0000.00% ROIMDTMedtronic11/19/2025Boost Price Target$100.83$109.00Neutral$0.0000.00% ROILIVNLivaNova11/13/2025Boost Price Target$56.62$70.00Outperform$0.0000.00% ROILIVNLivaNova11/6/2025Boost Price Target$49.07$63.00Outperform$0.0000.00% ROIMMSIMerit Medical Systems10/31/2025Set Price Target$86.39$103.00$0.0000.00% ROIEWEdwards Lifesciences10/31/2025Set Price Target$82.44$83.00$0.0000.00% ROIBSXBoston Scientific10/1/2025Boost Price Target$97.55$128.00Outperform$0.0000.00% ROILouis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.Get the name and ticker of Louis Navellier's #1 AI stock freeMDTMedtronic8/20/2025Boost Price Target$89.92$96.00Neutral$0.0000.00% ROIPENPenumbra7/30/2025Boost Price Target$256.22$285.00Outperform$000.0000.00% ROIPENPenumbra7/30/2025Set Price Target$253.08$310.00Buy$000.0000.00% ROIEWEdwards Lifesciences7/25/2025Boost Price Target$75.68$79.00Neutral$00.0000.00% ROIBSXBoston Scientific7/24/2025Boost Price Target$107.51$123.00Outperform$00.0000.00% ROIHAEHaemonetics6/26/2025Initiated Coverage$73.52$87.00Outperform$00.0000.00% ROIMDTMedtronic5/22/2025Lower Price Target$81.62$92.00Neutral$00.0000.00% ROILIVNLivaNova5/8/2025Boost Price Target$43.51$61.00Outperform$00.0000.00% ROIMMSIMerit Medical Systems4/25/2025Lower Price Target$94.67$110.00Outperform$00.0000.00% ROIPENPenumbra4/24/2025Boost Price Target$278.18$325.00Outperform$000.0000.00% ROIEWEdwards Lifesciences4/24/2025Boost Price Target$70.33$75.00Neutral$00.0000.00% ROIBSXBoston Scientific4/24/2025Boost Price Target$99.01$120.00Outperform$00.0000.00% ROIPENPenumbra4/24/2025Boost Price Target$291.34$330.00Buy$000.0000.00% ROIISRGIntuitive Surgical4/23/2025Lower Price Target$478.74$575.00Outperform$000.0000.00% ROIPENPenumbra4/11/2025Lower Price Target$267.12$315.00Buy$000.0000.00% ROIISRGIntuitive Surgical3/18/2025Lower Price Target$488.80$600.00Outperform$000.0000.00% ROIPENPenumbra2/19/2025Boost Price Target$270.99$328.00Outperform$000.0000.00% ROIMDTMedtronic2/19/2025Boost Price Target$86.05$91.00Neutral$00.0000.00% ROIPENPenumbra2/19/2025Boost Price Target$307.06$325.00Buy$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenWeiss RatingsUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank Aktiengesellschaft Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
